Compounds > 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
Page last updated: 2024-08-26

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Chronic Hepatitis

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Chronic Hepatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornides, A; Fehér, J; Gógl, A; Pollák, Z; Sréter, L; Toncsev, H; Vereckei, A1

Other Studies

1 other study(ies) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Chronic Hepatitis

ArticleYear
Experimental models for the study of hepatoprotection.
    Acta physiologica Hungarica, 1984, Volume: 64, Issue:3-4

    Topics: Animals; Catechin; Chemical and Drug Induced Liver Injury; Chronic Disease; Enzymes; Granulocytes; Hepatitis, Chronic; Humans; Liver; Liver Diseases; Lysosomes; Malondialdehyde; Mice; Quinolines

1984